...
首页> 外文期刊>Macromolecular bioscience >Novel hydrogel membrane based on copoly(hydroxyethyl methacrylate/p-vinylbenzylpoly(ethylene oxide)) for biomedical applications: Properties and drug release characteristics
【24h】

Novel hydrogel membrane based on copoly(hydroxyethyl methacrylate/p-vinylbenzylpoly(ethylene oxide)) for biomedical applications: Properties and drug release characteristics

机译:基于共聚(甲基丙烯酸羟乙酯/对乙烯基苄基聚(环氧乙烷))的新型水凝胶膜的生物医学应用:性质和药物释放特性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to synthesize and characterize a novel biocompatible polymeric membrane system and demonstrate its potential use in various biomedical applications. Synthetic hydrogels based on poly(hydroxyethyl methacrylate), poly(HEMA), have been widely studied and used in biomedical fields. A novel copolymer hydrogel was prepared in the membrane form using 2-hydroxyethyl methacrylate monomer (HEMA) and a macromonomer p-vinylbenzyl-poly(ethylene oxide) (V-PEO) via photoinitiated polymerization. A series of poly(HEMA/V-PEO) copolymer membranes with different compositions were prepared. The membranes were characterised using infrared, thermal and SEM analysis. The thermal stabilities of the copolymer membranes were found to be lowered by an increase in the ratio of macromonomer (V-PEO) in the membrane structure. Because of the incorporation of PEO segments, the coplymers exhibited significantly higher hydropholic surface properties than pure poly(HEMA), as demonstrated by contact angle measurements. Equilibrium swelling studies were conducted to investigate the swelling behavior of the membrane. The equilibrium water uptake was reached in about 4 h. Moreover, the blood protein adsorption and platelet adhesion were significantly reduced on the surface of the PEO contacting copolymer membranes compared to control pure poly(HEMA). Drug release experiments were performed in a continuous release system using model drug (vancomycin) loaded copoly(HEMA/V-PEO) membrane formulation possessing the highest PEO contact (with a HEMA:V-PEO (mmol:mmol) feed ratio of 112:1 and loaded with 40 mg antibiotic/g polymer) released and can be considered as a potential candidate for a transdermal antibiotic carrier and various biomedical and biotechological applications.
机译:这项研究的目的是合成和表征新型的生物相容性聚合物膜系统,并证明其在各种生物医学应用中的潜在用途。基于聚(甲基丙烯酸羟乙酯),聚(HEMA)的合成水凝胶已被广泛研究并用于生物医学领域。通过光引发聚合反应,使用甲基丙烯酸2-羟乙酯(HEMA)和大单体对乙烯基苄基聚(环氧乙烷)(V-PEO),以膜形式制备了新型共聚物水凝胶。制备了一系列具有不同组成的聚(HEMA / V-PEO)共聚物膜。使用红外,热和SEM分析对膜进行表征。发现通过增加膜结构中大分子单体(V-PEO)的比例,共聚物膜的热稳定性降低。由于引入了PEO链段,因此与接触角测量法相比,该共聚物表现出比纯聚(HEMA)更高的疏水表面性能。进行平衡溶胀研究以研究膜的溶胀行为。在约4小时内达到平衡的水吸收。此外,与对照纯聚(HEMA)相比,PEO接触共聚物膜表面的血液蛋白吸附和血小板粘附显着降低。药物释放实验是在连续释放系统中进行的,使用具有最高PEO接触量(HEMA:V-PEO(mmol:mmol)进料比为112:PE)的模型药物(万古霉素)负载的共聚(HEMA / V-PEO)膜制剂。 1并装有40 mg抗生素/ g聚合物释放),可以被认为是透皮抗生素载体以及各种生物医学和生物技术应用的潜在候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号